HLJ1 is an endogenous Src inhibitor suppressing cancer progression through dual mechanisms.
Chen CH, Chang WH, Su KY, Ku WH, Chang GC, Hong QS, Hsiao YJ, Chen HC, Chen HY, Wu R, Yang PC, Chen JJ, Yu SL.
Chen CH, et al. Among authors: wu r.
Oncogene. 2016 Oct 27;35(43):5674-5685. doi: 10.1038/onc.2016.106. Epub 2016 Apr 11.
Oncogene. 2016.
PMID: 27065329